179 related articles for article (PubMed ID: 20394697)
21. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
Coughlin SS; King J
BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study.
Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L
Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048
[TBL] [Abstract][Full Text] [Related]
23. A Randomized Controlled Trial of a Cervical Cancer Education Intervention for Latinas Delivered Through Interactive, Multimedia Kiosks.
Valdez A; Napoles AM; Stewart SL; Garza A
J Cancer Educ; 2018 Feb; 33(1):222-230. PubMed ID: 27573420
[TBL] [Abstract][Full Text] [Related]
24. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
25. Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.
Bukowski A; Smith JS; Wheeler SB; Sanusi B; McGuire FH; Zeno E; Des Marais AC; Barclay L; Hudgens MG; Jackson S; Brewer NT
J Womens Health (Larchmt); 2023 Sep; 32(9):970-981. PubMed ID: 37327372
[No Abstract] [Full Text] [Related]
26. Sociodemographic factors of Pap smear screening in Taiwan.
Wang PD; Lin RS
Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
[TBL] [Abstract][Full Text] [Related]
27. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
28. Individual- and county-level predictors of cervical cancer screening: a multi-level analysis.
Akinlotan MA; Weston C; Bolin JN
Public Health; 2018 Jul; 160():116-124. PubMed ID: 29803186
[TBL] [Abstract][Full Text] [Related]
29. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
30. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
Katz SJ; Hofer TP
JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
[TBL] [Abstract][Full Text] [Related]
31. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
32. Utilization of papanicolaou smears by South Asian women living in the United States.
Chaudhry S; Fink A; Gelberg L; Brook R
J Gen Intern Med; 2003 May; 18(5):377-84. PubMed ID: 12795737
[TBL] [Abstract][Full Text] [Related]
33. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
Phaswana-Mafuya N; Peltzer K
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
[TBL] [Abstract][Full Text] [Related]
34. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
35. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
36. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
37. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with underscreening for cervical cancer among women in Canada.
Schoueri-Mychasiw N; McDonald PW
Asian Pac J Cancer Prev; 2013; 14(11):6445-50. PubMed ID: 24377548
[TBL] [Abstract][Full Text] [Related]
39. Association of Body Mass Index With Adherence to Cervical Cancer Screening Recommendations in Hispanic Women.
Pérez CM; González-Barrios D; Ramos-Cartagena JM; Ortiz AP
J Low Genit Tract Dis; 2020 Jan; 24(1):14-20. PubMed ID: 31860570
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]